Quince Therapeutics, Inc. (QNCX)

NASDAQ: QNCX · IEX Real-Time Price · USD

0.738

+0.013 (1.72%)

At close: Jul 2, 2024, 4:00 PM

0.746

+0.008 (1.08%)

After-hours: Jul 2, 2024, 6:10 PM EDT

Quince Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018 - 2017
Market Capitalization	32	45	23	377	819	1,507	Upgrade
Market Cap Growth	-19.70%	95.46%	-93.89%	-53.99%	-45.64%	-	Upgrade
Enterprise Value	-22	-16	-67	271	686	1,408	Upgrade
PE Ratio	-	-1.43	-0.45	-4.19	-10.66	-40.76	Upgrade
PB Ratio	0.43	0.53	0.23	3.18	4.76	13.05	Upgrade
P/FCF Ratio	-1.96	-2.45	-0.52	-5.97	-16.11	-45.23	Upgrade
P/OCF Ratio	-1.97	-2.46	-0.52	-5.99	-16.13	-45.30	Upgrade
EV/EBITDA Ratio	0.28	0.52	1.30	-3.02	-8.96	-38.26	Upgrade
EV/EBIT Ratio	0.28	0.52	1.29	-3.01	-8.92	-38.06	Upgrade
EV/FCF Ratio	0.36	0.89	1.52	-4.29	-13.48	-42.23	Upgrade
Debt / Equity Ratio	0.19	0.16	-	0.00	0.00	-	Upgrade
Debt / EBITDA Ratio	-0.47	-0.44	-	0.00	0.00	-	Upgrade
Debt / FCF Ratio	-0.60	-0.75	-	-0.01	0.00	-	Upgrade
Quick Ratio	6.89	7.84	29.38	7.51	7.87	11.23	Upgrade
Current Ratio	7.16	8.09	30.55	7.85	8.11	11.93	Upgrade
Return on Equity (ROE)	-36.80%	-36.40%	-48.80%	-65.40%	-39.20%	-43.40%	Upgrade
Return on Assets (ROA)	-24.20%	-28.80%	-46.20%	-58.40%	-36.40%	-31.40%	Upgrade
Return on Capital (ROIC)	-32.54%	-33.43%	-51.71%	-75.89%	-45.74%	-33.92%	Upgrade
Earnings Yield	-95.01%	-69.73%	-224.32%	-23.85%	-9.38%	-2.45%	Upgrade
FCF Yield	-72.60%	-40.79%	-191.50%	-16.74%	-6.21%	-2.21%	Upgrade
Buyback Yield / Dilution	-19.96%	-11.17%	-12.71%	-1.86%	-53.30%	-466.06%	Upgrade
Total Shareholder Return	-19.96%	-11.17%	-12.71%	-1.86%	-53.30%	-466.06%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).